Vanda Pharmaceuticals Inc. v. Apotex Inc.
1:24-cv-01344
Overview
Parties
Defendant
Plaintiff
Vanda Pharmaceuticals Inc. Operating Company
Represented By
7 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 17 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 11,918,556 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2024019767 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2025016125 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012615909 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012616400 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012616504 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012617141 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012617389 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2013617558 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,785,492 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,060,995 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,539,234 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,149,829 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,610,510 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,980,770 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11918556
Treatment of circadian rhythm disorders
|
Filed: 2022-02-15
Issued: 2024-03-05
|
Active (6.4 yrs remaining)
Expires: 2033-04-07
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
0
Granted
0
Denied
0
Pending / Review
3
Motions by Category
Key Dispositive Motions & Rulings